Motley Fool Premium
  1. Authors
    2. /
  2. Megan Boxall
    3. /

Megan Boxall

Recent Articles

Syringe and vial on blue background
Investing Articles

The Oxford Biomedica share price has doubled since signing its Covid-19 vaccine deal. Can the momentum continue?

| Megan Boxall

Oxford Biomedica’s share price is soaring. But is this simply the hype of its Covid-19 vaccine deal? Megan Boxall examines…

Read more »